FKBP10 expression and TP53 mutation predict prognosis and chemotherapy response in triple-negative breast cancer
Abstract Background Triple-negative breast cancer (TNBC) lacks targeted therapies. FKBP10 contributes to oncogenesis and chemoresistance. We investigated FKBP10’s prognostic value in TNBC. Methods We retrospectively analyzed 190 TNBC patients receiving neoadjuvant chemotherapy. Patients were stratif...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer
2025-07-01
|
| Серии: | Discover Oncology |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1007/s12672-025-03275-8 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|